Informed Consent Guidance Allows Discussion Of Specimen "Donation"
Executive Summary
Sponsors of clinical trials can now include language in informed consent forms explaining that subjects are "donating" their blood, tissue or urine samples; previously, the term had been discouraged because of concern that it released sponsors from liability.
You may also be interested in...
FDA Will Revise Investigator Disqualification Regs In Response To GAO Report
The agency will revise its regulations to prevent clinical investigators who are disqualified from running trials for one product type to continue leading studies for other FDA-regulated categories.
Janssen’s Sirturo Needs Minor Tweaks To Confirmatory Trial, FDA Panel Says
Gathering more data to assuage concerns about possibly lower efficacy in black patients will be key to converting the accelerated approval to full approval for the tuberculosis drug, FDA’s Anti-Infective Drugs Advisory Committee concludes.
Ranbaxy’s Atorvastatin Recall: Will Glass Shards Nick FDA’s Reputation?
Less than a year after signing a consent decree to resolve compliance problems, the company is forced to stop manufacturing its generic version of the best-selling cholesterol drug. For FDA, the issue poses a public relations challenge since it touches on several areas where the agency has recently been criticized – generic drug quality, manufacturing oversight and drug shortages.